MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMLS AHWEKKKTSL VELQEQLQQL PALIADLESM TANLTHLEAS FEEVENNLLHLEDLCGQCEL ERCKHMQSQQ LENYKKNKRK ELETFKAELD AEHAQKVLEM EHTQQMKLKE RQKFFEEAFQ QDMEQYLSTG YLQIAERREP IGSMSSMEVN VDMLEQMDLM DISDQEALDV FLNSGGEENT VLSPALGPES STCQNEITLQ VPNPSELRAK PPSSSSTCTD SATRDISEGG ESPVVQSDEE EVQVDTALAT SHTDREATPD GGEDSDS.
Dystrobrevin-Binding Protein 1 (DTNBP1), also known as dysbindin, is a protein encoded by the DTNBP1 gene located on chromosome 6p22.3. This protein is a part of the dystrophin-associated protein complex (DPC), which plays a crucial role in linking the cytoskeleton to the extracellular matrix and serves as a scaffold for signaling proteins .
DTNBP1 has multiple isoforms, with Isoform C being one of them. Isoform C is a human recombinant protein, meaning it is produced through recombinant DNA technology, which allows for the expression of the protein in a host organism, typically bacteria or yeast. This method ensures a high yield and purity of the protein for research and therapeutic purposes .
Dysbindin, including its Isoform C, is an essential component of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). It interacts with all seven other components of BLOC-1, playing a significant role in the formation and function of lysosome-related organelles . Additionally, dysbindin is involved in synaptic function and neurotransmitter release, particularly in glutamatergic neurons .
DTNBP1 has been extensively studied for its association with schizophrenia. Several studies have reported significant associations between schizophrenia and certain haplotypes of single-nucleotide polymorphisms (SNPs) in the DTNBP1 gene . Dysbindin-1 reductions have been observed in the hippocampal formation of individuals with schizophrenia, suggesting its role in the cognitive deficits associated with the disorder .
The human recombinant form of Dystrobrevin-Binding Protein 1 Isoform C is widely used in research to study its function and role in various biological processes. It is also utilized in drug development and therapeutic research, particularly in understanding and potentially treating neurological disorders such as schizophrenia .